Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Professional safety for oncology nurses
Nellie Kumaralingam - The Royal Marsden NHS Foundation Trust, London, UK
Professional safety for oncology nurses ( Nellie Kumaralingam - The Royal Marsden NHS Foundation Trust, London, UK )
13 Jan 2020
Endocrine dysfunction in patients receiving immunotherapy
Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK
Endocrine dysfunction in patients receiving immunotherapy ( Sherwin Criseno - University Hospitals Birmingham, Birmingham, UK )
13 Jan 2020
Are remissions for AML patients 'better' after daunorubicin and cytarabine...
Prof Daniel Ryan - University of Rochester, Rochester, USA
Are remissions for AML patients 'better' after daunorubicin and cytarabine liposome injection ( Prof Daniel Ryan - University of Rochester, Rochester, USA )
24 Dec 2019
Is enasidenib plus azacitidine better than with azacitidine alone for AML...
Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA
Is enasidenib plus azacitidine better than with azacitidine alone for AML patients? ( Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA )
24 Dec 2019
PET-Directed therapy for early-stage diffuse large B-cell lymphoma
Prof Daniel Persky - University of Arizona Cancer Center, Tucson, USA
PET-Directed therapy for early-stage diffuse large B-cell lymphoma ( Prof Daniel Persky - University of Arizona Cancer Center, Tucson, USA )
24 Dec 2019
Lenalidomide maintenance for transplant eligible and transplant ineligible...
Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK
Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )
24 Dec 2019
Dasatinib vs imatinib in the treatment of paediatric ALL
Dr Shuhong Shen - National Children's Medical Center, Shanghai, China
Dasatinib vs imatinib in the treatment of paediatric ALL ( Dr Shuhong Shen - National Children's Medical Center, Shanghai, China )
24 Dec 2019
The importance of central pathology pCR review in an international multicenter...
Dr Hans-Christian Kolberg - Marienhospital, Bottrop, Germany
The importance of central pathology pCR review in an international multicenter neoadjuvant study in HER2 positive early BC ( Dr Hans-Christian Kolberg - Marienhospital, Bottrop, Germany )
19 Dec 2019
SABCS 2019 highlights
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2019 highlights ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
19 Dec 2019
KEYNOTE-522: Neoadjuvant pembro chemo vs placebo chemo, followed by...
Dr Jay Andersen - Compass Oncology West Cancer Center, Tigard, USA
KEYNOTE-522: Neoadjuvant pembro chemo vs placebo chemo, followed by adjuvant pembro vs placebo for early TNBC ( Dr Jay Andersen - Compass Oncology West Cancer Center, Tigard, USA )
19 Dec 2019
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
19 Dec 2019
Pathologic complete response rates improved with the neoadjuvant and adjuvant...
Prof Peter Schmid - St Bartholomew's Hospital London, London, UK
Pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembrolizumab in TNBC patients ( Prof Peter Schmid - St Bartholomew's Hospital London, London, UK )
18 Dec 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation